Breaking News
April 25, 2019 - Prolonged exposure therapy is more effective in treating veterans with PTSD, alcohol use disorder
April 24, 2019 - Our artificial cornea breakthrough could lead to self-assembling organs
April 24, 2019 - A Stanford black, female, gay surgery resident speaks out
April 24, 2019 - Donna Lynne on Extreme Sports, Lessons From the '60s, and Taking CUIMC to the Next Level
April 24, 2019 - Pain Clinics’ Doctors Needlessly Tested Hundreds Of Urine Samples, Court Records Show
April 24, 2019 - Researchers uncover potential clue to halt destruction of nerve cells in people with ALS
April 24, 2019 - Study uncovers reasons for poor mental health in bisexual people
April 24, 2019 - Screenings, interventions, and referrals can help adolescents overcome substance abuse
April 24, 2019 - Febrile seizures following vaccination are self-resolving and not dangerous
April 24, 2019 - Flow-UV inline UV-Visible spectrometer monitors dispersion in real time
April 24, 2019 - Rates of Marijuana Use in Cancer Patients on the Rise in U.S.
April 24, 2019 - Versatile drug may protect baby from hazards of intraamniotic infections
April 24, 2019 - Financial transparency may diminish trust in doctors, new study finds
April 24, 2019 - Calling all Riders: Velocity Extends Free Registration 
April 24, 2019 - The Homeless Are Dying In Record Numbers On The Streets Of L.A.
April 24, 2019 - Simple mobility test helps predict hospital readmission in elderly heart attack patients
April 24, 2019 - Novel fluorescence imaging system helps surgeons remove small ovarian tumors
April 24, 2019 - Uncovering the Structure of HIV Integrase to Inform Drug Discovery
April 24, 2019 - Medical Marijuana Use Rising Among Cancer Patients
April 24, 2019 - Artificial intelligence approach optimizes embryo selection for IVF
April 24, 2019 - Doctor or detective? Sleuthing mysteries in medical school
April 24, 2019 - CUIMC Community Gives Blood During Spring 2019 Columbia University Blood Drive
April 24, 2019 - Americans Overwhelmingly Want Federal Protections Against Surprise Medical Bills
April 24, 2019 - Making Laboratories More Efficient with the Most Modern LIMS on the Market
April 24, 2019 - Treating cancer patients with personalized, combination therapies improves outcomes
April 24, 2019 - Researchers engineer new molecules to help stop lung cancer
April 24, 2019 - Acupuncture can be a wonderful tool for preventing number of diseases
April 24, 2019 - Daily life disability before hip replacement may predict poor post-operative outcomes
April 24, 2019 - Study finds involuntary staying in housing estates to be a potential health risk
April 24, 2019 - Older kidney disease patients starting dialysis die at higher rates than previously thought
April 24, 2019 - Time-restricted eating shows promise for controlling blood glucose levels
April 24, 2019 - Ambiguous genitalia in newborns may be more common than previously thought
April 24, 2019 - Research provides important insight on the brain-body connection
April 24, 2019 - In 10 Years, Half Of Middle-Income Elders Won’t Be Able To Afford Housing, Medical Care
April 24, 2019 - Researchers study how E. coli clones have become major cause of drug-resistant infections
April 24, 2019 - Bacterial and fungal toxins found in popular electronic cigarettes
April 24, 2019 - Factors affecting absorption of ‘sunshine vitamin’ during spring/summer months
April 24, 2019 - Texting helps improve medication adherence, health outcomes for patients with schizophrenia
April 24, 2019 - Cochrane Review looks at different ways to use nicotine replacement therapies
April 24, 2019 - New review on relationship between COPD and Type 2 diabetes
April 24, 2019 - Brain areas linked to memory and emotion aid odor navigation in humans
April 24, 2019 - Brain stimulation reverses age-related memory loss
April 24, 2019 - Amid Opioid Prescriber Crackdown, Health Officials Reach Out To Pain Patients
April 24, 2019 - $4 million NIH award will help establish UCI Skin Biology Resource-based Center
April 24, 2019 - Cancer drugs reprogram genes in breast tumors to prevent endocrine resistance, finds study
April 24, 2019 - Combination-imaging technique provides new window into macaque brain connections
April 24, 2019 - Researchers identify new allergen responsible for allergy to durum wheat
April 24, 2019 - Researchers define role of rare, influential cells in the bone marrow
April 24, 2019 - DNA rearrangement may predict poor outcomes in multiple myeloma
April 24, 2019 - FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis
April 24, 2019 - Combination therapy might be beneficial in schizophrenia
April 24, 2019 - Blood test can help match cancer patients to early phase clinical trials
April 24, 2019 - Women tend to underreport snoring and underestimate its loudness
April 24, 2019 - Comprehensive molecular test introduced for diagnosis of malaria caused by P. vivax parasites
April 24, 2019 - New range prediction approach increases accuracy, safety and tolerability of proton therapy
April 24, 2019 - Need for Sedation Up for Regular Cannabis Users
April 24, 2019 - Lack of access to antibiotics is a major global health challenge
April 24, 2019 - New study provides better understanding on safety of deworming programs
April 24, 2019 - EEG used to detect impact of maternal stress on neurodevelopment in 2-month-old infants
April 24, 2019 - FDA Approves First Generic Naloxone Nasal Spray Against Opioid Overdose
April 24, 2019 - A new way of finding compounds that prevent aging
April 24, 2019 - Mechanical training makes synthetic hydrogels perform more like muscle
April 24, 2019 - Study provides new insights into regulatory T cells’ role in protecting against autoimmune disease
April 24, 2019 - Pregnant women with type 1 diabetes are at greater risk of preterm birth
April 24, 2019 - ‘Tummy tuck’ can be safely performed in obese patients with no increase in complications
April 23, 2019 - ‘First’ 3-D print of heart with human tissue, vessels unveiled
April 23, 2019 - Which blood-based method works best to detect TB?
April 23, 2019 - Gene therapy cures infants suffering from ‘bubble boy’ immune disease
April 23, 2019 - Chemical-sampling wristbands detect similar exposures across three continents
April 23, 2019 - Management of Residual Limb Pain
April 23, 2019 - Molecular clock influences immune cell responses
April 23, 2019 - On the importance of culture, partnerships and diversity at the Dean’s Lecture Series
April 23, 2019 - Siddhartha Mukherjee Receives Lewis Thomas Prize for Writing About Science
April 23, 2019 - Dengue mosquito poses greatest danger of spreading Zika virus in Australia
April 23, 2019 - Scientists identify 104 high-risk genes for schizophrenia
April 23, 2019 - Abdominal etching can help patients to get classic ‘six-pack abs’ physique
April 23, 2019 - Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal System Due to Product Mislabeling
April 23, 2019 - Skype hypnotherapy is effective treatment for IBS
April 23, 2019 - The future hope of “flash” radiation cancer therapy
April 23, 2019 - Bicycling, Recycling, and Beyond: Public Safety to Host Shred Fest and Bike-to-Campus Day 
From Our Bench to Yours: Antibody Advice from Proteintech

From Our Bench to Yours: Antibody Advice from Proteintech

image_pdfDownload PDFimage_print

Please can you introduce yourself and the role you carry out at Proteintech?

I am a technical scientist and product manager at Proteintech. My role involves helping our customers optimize their research results and address any concerns through technical support by sharing our experimental tips and engaging scientists via our blog channel. I also write articles on upcoming techniques and novel applications of our products.

molekuul_bemolekuul_be | Shutterstock

I also run technical masterclasses for young scientists, along with training webinars. Our next masterclass is on January 29, 2019, at the University of Newcastle, where we’ll be teaching students to master western blotting and immunofluorescence, including tips on how to optimize your protocols and overcome common experimental obstacles.

What makes an antibody good or bad? How can a scientist tell if a seller is trustworthy or not?

When generating an antibody, you can either immunize with a whole protein or a small synthetic peptide fragment that you are interested in detecting. At Proteintech, we take a whole protein approach to the antibodies we offer as this provides several benefits for the researcher.

Ninety-five percent of Proteintech antibodies are raised against whole proteins, letting the immune system choose the best epitopes for generating antibodies. This approach provides superior antibody binding to the native target protein at multiple epitopes compared to peptide immunogens, and secondly, the specificity and sensitivity of the assay are improved.

The final advantage is that the antibody can be used in more applications. For example, many assays can be used to study a single antigen, but each assay may require a slightly different antibody depending on the epitope.

Some regions of the protein may be better for one application than another, so the availability of the whole protein yields antibodies that can work for multiple applications. This is more likely to occur with a whole protein approach compared to a single fragment. Since the immune system can generate antibodies against any region of the whole protein, there is also a high chance of reactivity across species due to conservation.

To summarize, the three main advantages of whole-protein antibodies are:

  • wider applicability,
  • higher binding sensitivity and affinity,
  • superior recognition of native, intact proteins.

Another sign of reliability is whether the company selling the antibody is a manufacturer and distributor, or just a distributor (re-seller). This is important because if you have an issue or query about an antibody, you need to be able to obtain RAW validation data. If that data has not been collected in-house, it will take longer for the company to collate it, which can potentially delay your experiments.

Proteintech – a direct manufacturer (Credit: Proteintech)

At Proteintech, all of our data is freely available online and our antibodies have been cited in hundreds of publications. When an obscure application is queried, we can provide the validation data to support or refute the experiment and do so within 24 hours. We are proud to show realistic data that hasn’t been “cleaned up” to look perfect but will give you an idea of how the western blot, for example, will look time and time again. I think that’s a particularly good sign of trustworthiness.

Why is reproducibility important and how do Proteintech ensure this for each of their antibodies?

Every scientist wants to get the same results every time when working with the same antibody. As I mentioned, we are the only manufacturer, so we can provide instant support for scientists who are troubleshooting their methods.

Another sign of quality is the purification method used. We use affinity chromatography, which makes use of the binding strength of a protein for its ligand. Another popular method is protein A/G purification, which uses the recombinant fusion protein A/G from E. coli. Protein A/G purification will yield all IgGs in the serum, not just the desired antibodies. Affinity chromatography selects for just the ones with the highest affinity toward the target.

We also validate our antibodies through knockout and knockdown (KO/KD) studies. Proteintech was the first company to implement siRNA knockdown validation experiments, the gold standard for testing antibody specificity. The validation process involves using small interfering RNA to knock down gene expression in an antibody product – assessing whether the signal subsides with the expression of the target gene.

This is critical for ensuring consistent and reliable results and is far superior to validation using positive controls only. In 2016 we were awarded the CiteAb prize for the ‘most exciting antibody validation initiative’.

The following year, Proteintech was the company with the largest percentage increase in citations based on data gathered between January 2017 and December 2017 (“Highly commended antibody supplier’ in CiteAb 2018 awards”).

We also compare all of our antibodies lot-to-lot, which helps us to detect changes in performance between batches. If a new lot fails to perform either as well as or better than the previous one, it is unsellable, and we begin production on another lot.

Is it possible to use the same antibody for multiple applications? How are Proteintech working to improve this?

As scientists, we would love to have one antibody for all applications, but unfortunately, this is a challenge. Simply put, the biochemistry of each assay is markedly different. For example, in Westerns, the protein is denatured, but in immunohistochemistry (IHC), the protein is in native form in its cellular context.

However, one thing we are trying to do as a company is to provide antibody specific protocols, that a scientist can find easily on our website. This might mean a slightly longer incubation time, an antigen retrieval step (in the case of IHC or IF), or a different blocking step, etc.

You recently purchased Humanzyme, a company that produces recombinant human proteins. Why did you feel this was a necessary step for Proteintech and what advantages do recombinant proteins provide?

For over 15 years, we have been trying to create the best antibodies by bucking the trend of using peptides and instead using whole-protein immunogens. Humanzyme has been making the best proteins by forgoing bacteria and hamsters and using human cells (HEK293) to make human proteins with native glycosylation, multimerization, and processing. You could say that we go together like an antibody and a protein!

For human applications and research, a human cell expression system is ideal. I find this fascinating: Humanzyme products can be used to study native post-translational modification and protein folding in regenerative medicine.

Recombinant proteins provide many advantages over proteins derived from other organisms. The first major benefit is potency; recombinant cells produce proteins with a higher potency than E. coli-derived proteins, for example.

In addition, recombinant human proteins are glycosylated by protein chaperones, which are only available in eukaryotic cells. Insect and Chinese hamster ovary (CHO) cells cannot do this, and the result is a product that is less representative of the native protein and doesn’t work with many assays.

Comparison of proteins produced using different expression systems. Colored circles denote level of similarity to human proteins. (Credit: Proteintech)

What does the future look like for Proteintech?

For the next few years, we’ll be focusing on expanding our recombinant human protein products while also looking into new applications for our current products.

We recently launched a product line called CoraLite, which is a series of fluorescent-dye conjugated antibodies that can be used in immunofluorescence and flow cytometry. CoraLite allows scientists to produce beautiful IF images from direct labeling.

Coralite fluorescent-dye conjugated Proteintech antibodies (Credit: Proteintech)

Our hope is for Humanzyme to grow very quickly, especially when the products are approved for use in Good Manufacturing Practice (GMP) labs, which should be happening the next year. This will open the door for Proteintech to start working with more pharmaceutical and biomedical companies. Overall, the future looks bright!

Where can readers find more information?

For more information, please visit the Proteintech website.

About Karolina Szczesna

Dr. Karolina Szczesna is an experienced product and project manager with more than 7 years’ experience in coordinating multiple international projects, including project plans and management, testing novel screening methods, launching new products, and developing relationships between researchers and commercial partners.

Her scientific focus is related mostly to the Central Nervous System and Oncological Disease Models (e.g., cancer stem cells, cancer epigenetics, and studies related to rare neurodevelopment diseases). Karolina’s scientific achievements are reflected in more than 10 PubMed Publications.

At Proteintech she is a multilingual Product Manager and Technical Support Specialist, being responsible for the coordination of international collaborations and market branding worldwide, including speaking about science novelty and technology at top European universities.

About Proteintech

Proteintech is an antibody and human protein manufacturer selling directly to scientists and only selling its own products in order to maintain the highest level of quality control, leading to superior reproducibility and lot consistency. With over 2/3 of the human genome completed, we have a catalog of over 12,000 antibodies against 12,000 targets covering a wide spectrum of research areas.

We have been cited in tens of thousands of publications and provide in-house validation of our antibodies in WB, IHC, IF, FC, IP, and CHIP, in addition to performing siRNA knockdown validation of our antibodies. Additionally, we provide human cell-expressed proteins that have authentic glycosylation and folding, yielding higher activity and stability over proteins from other hosts.

Tagged with:

About author

Related Articles